The relation between cigarette smoking and mortality was examined prospectively in a population of adult insulin-dependent diabetes mellitus (IDDM) patients. In [1] [2] [3] 5, 6 In the nondiabetic population, cigarette smoking is clearly a major risk factor for death, particularly due to cardiovascular diseases.7 However, assessment of the health effects of cigarette smoking among IDDM populations has received little attention, despite both IDDM and smoking being highly associated with increased mortality. It is currently unknown whether or not lifestyle risk factors, such as smoking, are associated with an increased risk of death. Conceiv-
ably, such disease-related factors as duration and glycemic control may be such strong determinants of complications and mortality that any smoking effect would be minimal. The current research, therefore, prospectively investigated the relation of smoking to death in a large cohort of IDDM patients. Methods This study is the first prospective evaluation of the Pittsburgh IDDM Morbidity and Mortality Study population. A retrospective assessment of determinants of mortality in this population has previously been reported. 8 The subjects were drawn from the Children's Hospital of Pittsburgh IDDM registry, a description of which has previously been published. 9 Briefly, this is a registry of IDDM subjects diagnosed between 1950 and the present who met the following qualifications: 1) age at diagnosis less than 17 years, See p 299 2) discharged from hospital on insulin therapy, and 3) diagnosed or seen at Children's Hospital within 1 year of the date of diagnosis. For the mortality study, analysis was limited to the 723 subjects who were diagnosed between 1950 and 1964. Self-administered questionnaire data were collected in 1981 for 671 (93%) of the patients (by proxy for those who had died between 1950 and 1981). The 548 of these interviewed subjects who were alive as of January 1, 1982, com- Standardized mortality ratios (SMRs) were calculated using 1980 U.S. age-specific all-cause mortality rates to determine whether this population of diabetic individuals experienced a greater than expected mortality. Univariate comparisons of baseline demographic and risk factor variables were made using SPSSx t test and X2 test procedures.12 Cox regression was performed using the BMDP statistical package (University of California, Berkeley, California) to examine the independent contribution of smoking to mortality, allowing for varying periods of follow-up.
Results

All-Cause Mortality
Thirty-two males and 22 females died during the 6-year follow-up period. There was no significant difference in the unadjusted mortality rates for men and women (11.5% and 8.6%, respectively, p =0.34). Both males and females showed a significant excess mortality in comparison with the general population. Overall, the mortality rate for diabetic males was 19.8 per 1,000 person-years, in comparison with the expected rate of 2.3 per 1,000 person-years for nondiabetic males of the same age. For females, the corresponding rates were 14.6 per 1,000 person-years among diabetics and 1.1 per 1,000 person-years among nondiabetics. These rates represented an excess mortality of 8.7-fold for males and 13.7-fold for females. These SMRs are very similar to those reported based on a larger population in the retrospective mortality analysis.8 The large difference in SMRs for men and women reflects the relatively lower mortality rate in nondiabetic women as compared with nondiabetic men. Table 2 presents the univariate comparison of the deceased subjects and the survivors in relation to the smoking variables. The subjects who died showed higher rates for all five of the smoking variables, although the differences reached statistical significance only in females. In this and subsequent tables, "heavy" smoking refers to reported lifetime smoking of at least one pack per day for 5 or more years. This variable was selected as a focus for these analyses because it represents a measure of "dose" and should more accurately reflect the subjects' smoking history than any other available smoking variable. However, the results do not change substantially, regardless of the smoking variable included. In this population, nearly 80% of the heavy-smoking individuals were current smokers at baseline. The mortality experience of the cohort was compared for men and women, controlling for smoking status. As presented in Table 3 , there was no difference in mortality between male and female diabetics within smoking status category.
It was important to evaluate the contribution of smoking to the overall increased mortality risk compared with the general, nondiabetic population; therefore, SMRs were calculated according to sex and smoking status of the diabetic cohort. Among male diabetics, heavy smokers had an excess risk of death slightly higher than that of nonheavy smokers ( Figure 1 ). In contrast, diabetic women who smoked heavily had an excess mortality over 20 times that of the general population, whereas those who did not smoke heavily had a tenfold higher SMR. Again, this probably reflects the relatively higher mortality rates in nondiabetic men compared with women.
The association between smoking and mortality could be confounded by other potential risk factors for mortality. As presented in Table 4 , the subjects who died differed from the living subjects at baseline regarding several other variables. In order to determine the independent contribution of smoking, Cox proportional hazards analysis was used. Variables included in the model were those that were associated with mortality in the univariate analysis (p<0.10) and that are likely to confound the association between smoking and death, namely: age, physical activity level, body mass index, current drinking, and insulin dose per kilogram (duration of diabetes was not included in the model because of its dependence on age). Other variables that did not meet the specified level of significance -race, educational level, marital status, age at IDDM onset, and estrogen use -were excluded from the regression model. The regression was run both including and excluding a summary "complications" variable, which was coded "yes" if the individual reported severe eye disease, renal disease, or any macrovascular complication, and "no" if none of these IDDM complications was reported. The exclusion of reported complications from the model is probably the more appropriate analytic approach. If development of complications lies in the causal pathway between smoking and mortality-that is, if smoking "causes" both complications and mortality, and therefore, the effect of smoking on mortality is not independent of the effect of complications -then controlling for this factor would obscure the effect of smoking.
The multivariate results, presented in Only a few studies have investigated smoking as a determinant of death among diabetic individuals. A common deficiency in most of these studies is that insulin-dependent and noninsulin-dependent diabetes mellitus are not examined separately. Jarrett and Shipley14 reported no significant relation between smoking and mortality among middle-aged men followed for 10 years in the Whitehall study. Unfortunately, their population excluded women and contained few insulin-dependent' cases. In contrast, cigarette smoking was found to be a significant contributor to cardiovascular disease mortality among older diabetics in Rancho Bernardo15; again, however, few were insulin-dependent. In a follow-up of 371 diabetic cases identified from census data, Dupree and Meyer16 found no association between cigarette smoking and death. Because of the small number of deaths and their case definition (diabetics were defined as people between the ages of 20 and 75 years who reported taking antidiabetic medication within the 48 hours before interview), the results of this study are difficult to interpret. A recent prospective follow-up of the Wisconsin Epidemiologic Study of Diabetic Retinopathy population found significantly reduced survival in current smokers, both among young-onset insulin-using diabetics and the older-onset group. '7 This finding is consistent with our observation of an association between cigarette smoking and mortality.
Our group has previously examined this issue in a retrospective study, in which cigarette smoking was not associated with the risk of either mortality at all ages8 or of "late" mortality (after 26 years of age)18 in either males or females. The apparent inconsistency between our retrospective studies and the current prospective analysis may be due to potential biases in retrospective data collection. In the case-control studies, the source of the lifestyle information was different for cases and controls: surviving subjects generally responded for themselves, whereas for deceased subjects, the responses were reported by proxy respondents. In contrast, the current cohort includes only those alive at the time of the survey. Hence, bias due to differential outcome-dependent reporting of risk factors should be avoided.
Another important difference between the two investigations is that the prospective cohort consisted only of IDDM subjects who had survived through 1981, for an average of about 22 years postdiagnosis. The risk factors and causes of death for these longduration cases are clearly not representative of the mortality experience of all IDDM cases in the pop- ulation. When mortality at all ages was examined,18 the majority of deaths were due to acute diabetes complications or renal diseases; even in the "late" mortality group, 25% of the deaths were due to cardiovascular diseases and 55% were due to renal diseases. In contrast, 40% of the deaths in the prospective cohort were due to coronary diseases and only 25% were due to renal diseases. It is reasonable to expect that the risk factors would differ depending on the causes of mortality. A comparison of the death rates from this cohortboth crude mortality rates and mortality relative to the general population -revealed a striking pattern of excess mortality for women who smoked heavily, particularly coronary heart disease mortality. Similarly, smoking was recently found to increase the risk of coronary heart disease and coronary heart disease mortality among young and middle-aged nondiabetic women in a prospective analysis.19 It is not clear why the association in our diabetic cohort was much stronger for females than males. The relatively small sample size may have reduced the significance of the differences among men. Further research is needed to determine whether a sex interaction is present in other, larger population samples. The extremely high excess mortality seen among women as compared with the general population is in part explained by the lower mortality among women compared with men in the general population, especially in the younger age groups. Atherosclerosis is clearly much more prevalent in younger, nondiabetic men than women. Among relatively young insulin-dependent diabetic women, the interaction of smoking and diabetes may be important in increasing the risk of coronary disease mortality, whereas in men, the progressive vascular disease due to diabetes alone may substantially enhance the risk of heart attack, with little additional effect due to smoking.
Our regression results must be interpreted with caution because of the limited number of deaths in this cohort; however, the results suggest that diabetic individuals should avoid cigarette smoking. There is, however, little evidence that this message is reaching IDDM patients. In a case-control study in this population, the smoking behavior of IDDM cases was compared with that of sex-and age-matched nondiabetic siblings.20 Distressingly, diabetic individuals had smoking patterns identical to those of the nondiabetic individuals (Table 9) . Thus, despite their much more frequent contact with the health care system, the message to quit smoking, if given at all, is not being heeded.
A full understanding of the role that cigarette smoking plays in the etiology of diabetic complications and mortality in IDDM awaits further study; however, the prevention of unnecessary deaths by smoking avoidance or cessation must not be delayed. Our findings support the statement of Krall et a121 that "the time and effort spent ... in convincing patients not to smoke cigarettes will produce more useful years of life than almost all of the surgical miracles put together . . . [the use of tobacco among people with diabetes] should be absolutely banned."
